Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of UA021 in moderate-to-severe plaque psoriasis
CTR20253729Phase 2Active
- Sponsor
- U-SENSE Biopharma
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of UA021 in plaque psoriasis, sponsored by U-SENSE Biopharma. Started Oct 2025; status: active.
02
Drugs
UA021
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20253729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253729.